SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Renovo Plc.
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
40 5 0 RNVO.L
Emcee:  nigel bates Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
40(23rd November) Renovo Group plc (LSE : RNVO), the biopharmaceutical company devnigel bates-11/24/2010
39Just listened to the JPM webcast, which I thought was impressive.DewDiligence_on_SI-1/30/2008
38They also said worst case the mole market is 2%. And realistically the keloid keokalani'nui-12/13/2007
37Ouch. >>I thought company gave a pretty good explanation why the protocol nigel bates-12/13/2007
36Analysts now having serious doubts about whether co has dose nailed down. Effeckeokalani'nui-12/13/2007
35Looks like stock getting killed for J failing head and neck trial, but I thoughtkeokalani'nui-12/13/2007
34Writeup in the New Scientist: newscientist.com Nothing new, but a mention of thnigel bates-9/20/2007
33STATISTICALLY SIGNIFICANT EFFICACY OF JUVISTA® DEMONSTRATED IN PHASE 2 TRIAkeokalani'nui-9/12/2007
3228 August 2007 RENOVO GROUP PLC APPOINTMENT OF DR JOHN HUTCHISON AS CHIEF MEDInigel bates-8/29/2007
31Renovo Group plc Issue of Equity Pursuant to the announcement made on 17 Augustnigel bates-8/29/2007
30I've made worse... ..and plenty of them. Dunno about the choice of partnernigel bates-6/20/2007
29One of the best calls ever, Nigel. Congrats. Super deal. But did rnvo choose mkeokalani'nui-6/20/2007
28Royalty percentage "high teens" - >>...Some analysts expressed nigel bates-6/20/2007
27>>Love this one<< What I like is that the deal clearly didn't lnigel bates-6/20/2007
26The hot number(s) will be the royalty percentages - which I haven't got, as nigel bates-6/20/2007
25Seems like $75m is the new hot number. Nice.kenhott-6/20/2007
24Shire In-Licenses JUVISTA(R) (Human TGFbeta3) From Renovo BASINGSTOKE, England anigel bates-6/20/2007
23Nice. Love this one.keokalani'nui-4/17/2007
22RENOVO ANNOUNCES POSITIVE PHASE II EFFICACY TRIAL RESULTS FOR PREVASCAR Renovo nigel bates-4/17/2007
21Thanks for the reminder.keokalani'nui-3/5/2007
20Eleven months back, they promised a licensing deal within the next 12 months. Nnigel bates-3/5/2007
19Nice, thorough commentary by CEO. Thanks for the link.keokalani'nui-1/19/2007
18Annual report up on website - renovo.comnigel bates-1/19/2007
17TOTAL VOTING RIGHTS <pre>In conformity with the Transparency Directivenigel bates-1/5/2007
16The cosmeceuticals market has several things going for it from an investment staDewDiligence_on_SI-1/2/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News